Deeper Knowledge, Faster

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cipla
Medtronic
Mallinckrodt
Teva
Express Scripts
Johnson and Johnson
Covington
Julphar
Citi
Cantor Fitzgerald

Generated: January 17, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 090842

« Back to Dashboard

NDA 090842 describes RALOXIFENE HYDROCHLORIDE, which is a drug marketed by Amneal Pharms, Aurobindo Pharma Ltd, Glenmark Pharms Ltd, Invagen Pharms, Sciegen Pharms Inc, Teva Pharms Usa, and Watson Labs Inc, and is included in seven NDAs. It is available from eighteen suppliers. Additional details are available on the RALOXIFENE HYDROCHLORIDE profile page.

The generic ingredient in RALOXIFENE HYDROCHLORIDE is raloxifene hydrochloride. There are sixteen drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the raloxifene hydrochloride profile page.
Summary for 090842
Pharmacology for NDA: 090842
Suppliers and Packaging for NDA: 090842
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
RALOXIFENE HYDROCHLORIDE raloxifene hydrochloride TABLET;ORAL 090842 ANDA Liberty Pharmaceuticals, Inc. 0440-5295 0440-5295-01 100 TABLET, FILM COATED in 1 BOTTLE (0440-5295-01)
RALOXIFENE HYDROCHLORIDE raloxifene hydrochloride TABLET;ORAL 090842 ANDA Liberty Pharmaceuticals, Inc. 0440-5295 0440-5295-81 300 TABLET, FILM COATED in 1 BOTTLE (0440-5295-81)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength60MG
Approval Date:Sep 24, 2014TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Baxter
Moodys
McKinsey
Dow
Cipla
Express Scripts
Boehringer Ingelheim
Novartis
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot